Cidara Therapeutics, Inc. (CDTX)

Cidara Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	35.78	32.73	62.27	42.95	60.27
Cash & Cash Equivalents	35.78	32.73	62.27	42.95	60.27
Cash Growth	9.31%	-47.44%	44.99%	-28.74%	-19.17%
Receivables	16.25	5.83	5.36	11.18	0.01
Inventory	6.1	0	0	0	0
Other Current Assets	2.73	6.53	4.07	3.07	5.54
Total Current Assets	60.86	45.09	71.7	57.19	65.81
Property, Plant & Equipment	5.13	1.32	2.54	1.21	2.06
Other Long-Term Assets	1.05	1.07	1.08	2.02	1.1
Total Long-Term Assets	6.18	2.39	3.63	3.23	3.16
Total Assets	67.03	47.49	75.33	60.42	68.98
Accounts Payable	3.77	1.45	1.3	4.57	1.89
Deferred Revenue	29.34	35.14	32.33	25.01	9.8
Current Debt	1.3	1.21	3.74	7.96	10.78
Other Current Liabilities	33.01	3.6	-3.36	1.02	7.73
Total Current Liabilities	67.42	41.4	34.02	38.56	30.2
Long-Term Debt	3.58	0	1.32	0	0.94
Other Long-Term Liabilities	4.25	20.53	18.41	11.15	0
Total Long-Term Liabilities	7.82	20.53	19.74	11.15	0.94
Total Liabilities	75.24	61.93	53.75	49.71	31.14
Total Debt	4.88	1.21	5.06	7.96	11.73
Debt Growth	302.73%	-76.07%	-36.44%	-32.09%	18.10%
Retained Earnings	-441.43	-418.5	-377.17	-334.7	-259.83
Shareholders' Equity	-8.21	-14.44	21.57	10.72	37.84
Net Cash / Debt	30.9	31.52	57.21	34.99	48.54
Net Cash / Debt Growth	-1.96%	-44.91%	63.52%	-27.93%	-24.90%
Net Cash Per Share	7.07	9.02	21.81	16.84	32.43
Working Capital	-6.56	3.69	37.68	18.63	35.62
Book Value Per Share	-1.88	-4.13	8.23	5.16	25.28

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).